Two-stage transjugular intrahepatic porta-systemic shunt for patients with cirrhosis and a high risk of portal-systemic encephalopathy patients as a bridge to orthotopic liver transplantation: a preliminary report

Transplantation Proceedings
T WróblewskiM Krawczyk

Abstract

Placement of a transjugular intrahepatic porta-systemic shunt (TIPS) is a therapeutic option for the management of bleeding esophageal varices. However, the procedure is associated with an increased risk of portal-systemic encephalopathy (PSE). In this study, a two-stage modification of the standard TIPS technique was introduced for the management of variceal bleeding in cirrhotic patients with a high risk of PSE before liver transplantation. The modified procedure was applied to four patients with cirrhosis, portal hypertension, and ascites. Two had a history of encephalopathy after variceal bleeding; the other two were encephalopathic at the time of the first stage of the modified procedure. In the first stage, a 6-mm diameter intrahepatic shunt was created using a Palmaz-Schatz stent. One month later, in the second stage, the lumen of the shunt was expanded to a diameter of 10 mm. Both stages of this TIPS procedure were undertaken without any associated adverse events. In particular, neither stage was followed by a deterioration of neurologic status. From completion of the second stage to undertaking orthotopic liver transplantation (a period of 2 to 6 months), no rebleeding from esophageal varices occurred. A two-stage TIPS...Continue Reading

References

Sep 1, 1976·Annals of Surgery·R A MaltR B Malt
Aug 1, 1973·The British Journal of Surgery·R N PughR Williams
Aug 1, 1994·AJR. American Journal of Roentgenology·Z J HaskalC Cope
Jan 1, 1994·Cardiovascular and Interventional Radiology·H RousseauJ J Railhac
May 1, 1993·American Journal of Surgery·W S HeltonK Johansen
Sep 1, 1995·Journal of Vascular and Interventional Radiology : JVIR·C E EncarnacionS R Reuter
Jun 1, 1997·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·G KircheisS Stauch
Nov 5, 1997·Journal of Neurology, Neurosurgery, and Psychiatry·E A Jones, K Weissenborn
Dec 11, 1997·AJR. American Journal of Roentgenology·D A ZuckermanC F Hildebolt

❮ Previous
Next ❯

Citations

Dec 30, 2014·Journal of Vascular and Interventional Radiology : JVIR·Claus Christian PieperDaniel Thomas
Jan 11, 2020·Internal and Emergency Medicine·Francesco VizzuttiFabio Marra

❮ Previous
Next ❯

Related Concepts

Related Feeds

Aminoglycosides

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.

Aminoglycosides (ASM)

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.

Blood Clotting Disorders

Thrombophilia includes conditions with increased tendency for excessive blood clotting. Blood clotting occurs when the body has insufficient amounts of specialized proteins that make blood clot and stop bleeding. Here is the latest research on blood clotting disorders.

Related Papers

American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons
G P GuerriniA Burroughs
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society
Shahid HabibA Obaid Shakil
© 2021 Meta ULC. All rights reserved